Oncobox, RNA sequencing and molecular pathway analysis-base system for prescription of target drugs to advanced cancer patients

SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC

Decision support for precision oncology: Evolving from monotherapy to genomically informed combinations

CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer

Systems immunology in immuno-oncology

Highlights from WIN 2019

Innovation in clinical trials: WINTHER trial

A precision medicine approach to therapeutic resistance using KEAP1 somatic mutations

Rapidly changing landscape of precision medicine in Japan

Integration of DNA and RNA investigations in clinical trials: A laboratory challenge

Direct targeting of STAT3 alone and in combination with immune checkpoint inhibitors to treat solid tumours

Implementing national cancer control plans